DXB 1.23% 40.0¢ dimerix limited

Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-117

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,609 Posts.
    lightbulb Created with Sketch. 429
    This definitely is not a "bad" result. This drug has an effect not available with other current medications, so
    any improvement to someone with kidney disease is important - the sickest patients obtained benefit, and still
    expecting partnerships for Ph 3 in first haft of 2021. Imho still worth no less than last closing price.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
-0.005(1.23%)
Mkt cap ! $222.9M
Open High Low Value Volume
42.5¢ 43.0¢ 39.8¢ $436.4K 1.067M

Buyers (Bids)

No. Vol. Price($)
1 24999 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
41.0¢ 11224 1
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.